[ Back to EurekAlert! ]

Contact: B.D. Colen
bd_colen@harvard.edu
617-413-1224
Harvard University

Kevin Eggan, Ph.D., Harvard University

Caption: Kevin Eggan, a principal faculty member of the Harvard Stem Cell Institute and Professor in Harvard's Department of Stem Cell and Regenerative Biology is credited with first moving ALS -- Lou Gehrig's disease into a laboratory dish in 2008, paving the way for the study of treatments using human cells.

Credit: B.D. Colen/Harvard University

Usage Restrictions: The image may only be used with appropriate credit.

Related news release: Patient stem cells help identify common problem in ALS


[ Back to EurekAlert! ]